Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus–Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications
Modern Pathology · 2025-11 · 38 (11) · 100875
DOI: 10.1016/j.modpat.2025.100875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025-11. Verfasst von Barbara Burroni und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, GHU Paris Centre - Cochin, AP-HP, Paris, France; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Lymphoma, Follicular, T Follicular Helper Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Institutes of Health, Université de Paris, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
Follicular helper T-cell lymphomas (TFHLs) of the angioimmunoblastic type (AITL) and other TFHL variants often contain Epstein-Barr virus (EBV)-positive B blasts, but EBV infection of the neoplastic T cells has rarely been documented. Here, we report 10 cases of TFHL (9 AITLs and 1 TFHL not otherwise specified) associated with EBV infection in neoplastic T cells. The patients (5 men and 5 women), aged 56 to 81 years, presented with polyadenopathy (8/8), B symptoms (7/7), and skin lesions (4/7). EBV was confirmed in neoplastic follicular helper T-cell (TFH) by double labeling for EBV, T-cell markers (CD5 or CD3), and PD1/ICOS. In 2 patients, EBV infection in TFH was demonstrated in biopsies at relapse of an AITL (n = 2). In 3 cases, the abundance of EBV in large atypical B cells had led to a mistaken diagnosis of either classic Hodgkin lymphoma or EBV-positive large B-cell lymphoma, with the diagnosis subsequently confirmed as AITL in 2 of the 3 patients. A high viral load was observed in the 3 tested patients. Lymph node biopsies showed the typical pathological, phenotypic, and genetic features of TFHL with a CD4+ (10/10), CD10+ (5/10), PD1+ (10/10), ICOS+ (8/8), CXCL13+ (8/8), BCL6+ (5/9) TFH phenotype of the neoplastic cells, follicular dendritic cell expansion (9/10), and mutations in TET2 (10/10), RHOA (p.G17V variant in 8 cases and a previously unreported RHOA p.D120N variant in 1 case), DNMT3A (5/10), and CD28 (2/9) genes. Using PCR, type-1 EBV was detected in all 9 patients tested. All 7 patients with follow-up data available showed rapid disease progression and died 2-8 months after the diagnosis. This study shows that EBV type 1 can infect TFH cells in TFHL. Further studies are needed to understand whether the crosstalk between TFH cells and EBV-infected B cells plays a role in this phenomenon and to determine the potential clinical relevance of EBV in TFHL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, GHU Paris Centre - Cochin, AP-HP, Paris, France; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Team Inflammation, Complement and Cancer, Paris, France.
- Département de Pathologie, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France; Université Paris Est Créteil, Créteil, France; INSERMU955, Institut Mondor de Recherche Bi…
- Département de Pathologie, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France; Université Paris Est Créteil, Créteil, France.
- Department of Pathology, University Hospital of Nantes, IHP Group, Nantes, France.
- Department of Pathology, AP-HP. Sorbonne Université, Hôpital St Antoine, Paris, France.
- Service d'Anatomie et Cytologie Pathologiques, INSERM U1245-2, Centre Henri Becquerel, Rouen, France.
Förderung
- National Institutes of Health
- Université de Paris
- Institut National de la Santé et de la Recherche Médicale
- Universite Paris-Est Creteil Val de Marne
Zitieren
APA
Burroni, B., Lamaison, C., Poullot, E., Pirlog, R., Robe, C., Bossard, C., Fabiani, B., Veresezan, E. L., Sako, N., Pelletier, L., Labouyrie, E., Vincent, G., Lemonnier, F., Willems, L., Egan, C., Pittaluga, S., Rosenwald, A., de Leval, L., Jaffe, E. S., & Gaulard, P. (2025). Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus–Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications. Modern Pathology, 38(11), 100875. https://doi.org/10.1016/j.modpat.2025.100875
Vancouver
Burroni B, Lamaison C, Poullot E, Pirlog R, Robe C, Bossard C, et al. Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus–Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications. Modern Pathology. 2025;38(11):100875. doi:10.1016/j.modpat.2025.100875
BibTeX
@article{Burroni2025,
author = {Burroni, Barbara and Lamaison, Claire and Poullot, Elsa and Pirlog, Radu and Robe, Cyrielle and Bossard, Céline and Fabiani, Bettina and Veresezan, Elena-Liana and Sako, Nouhoum and Pelletier, Laura and Labouyrie, Eric and Vincent, Gabriel and Lemonnier, François and Willems, Lise and Egan, Caoimhe and Pittaluga, Stefania and Rosenwald, Andreas and de Leval, Laurence and Jaffe, Elaine S and Gaulard, Philippe},
title = {Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus–Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications},
journal = {Modern Pathology},
year = {2025},
volume = {38},
number = {11},
pages = {100875},
doi = {10.1016/j.modpat.2025.100875}
}
EUVIMED